Overview

GA 6: The Blood Glucose-lowering Effect of Glucose-dependent Insulinotropic Polypeptide

Status:
Completed
Trial end date:
2020-02-28
Target enrollment:
Participant gender:
Summary
This study will investigate if the effect of DPP-4 inhibitors is mediated in part by Glucose-dependent insulinotropic polypeptide.
Phase:
N/A
Details
Lead Sponsor:
University Hospital, Gentofte, Copenhagen
Treatments:
Dipeptidyl-Peptidase IV Inhibitors
Gastric Inhibitory Polypeptide
Sitagliptin Phosphate